Alfred W. Sandrock's most recent trade in Voyager Therapeutics Inc was a trade of 11,511 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on April 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 02 Apr 2026 | 11,511 | 472,549 (1%) | 0% | 3.9 | 44,548 | Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.78 per share. | 10 Feb 2026 | 12,192 | 509,989 (1%) | 0% | 3.8 | 46,086 | Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 402,500 | 402,500 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 86,250 | 522,181 (1%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 02 Apr 2025 | 10,885 | 430,931 (1%) | 0% | 3.4 | 37,336 | Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 290,000 | 290,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 145,000 | 441,816 (1%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 20 Feb 2025 | 11,702 | 296,816 (0%) | 0% | 4.2 | 49,616 | Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | President & CEO | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 11 Feb 2025 | 16,644 | 308,518 (0%) | 0% | 4.5 | 74,066 | Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 02 Apr 2024 | 12,115 | 322,839 (0%) | 0% | 9.9 | 119,454 | Common Stock |
| Voyager Therapeutics Inc | W. Alfred Sandrock | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.46 per share. | 21 Feb 2024 | 13,033 | 334,954 (0%) | 0% | 7.5 | 97,226 | Common Stock |
| Voyager Therapeutics Inc | W. Sandrock Alfred | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 260,000 | 260,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 130,000 | 347,987 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.83 per share. | 03 Apr 2023 | 7,437 | 214,618 (0%) | 0% | 7.8 | 58,232 | Common Stock |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 120,000 | 222,055 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 940,600 | 940,600 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Biogen | Alfred W. Sandrock | Head of Research & Development | Sale of securities on an exchange or to another person at price $ 440.00 per share. | 07 Jun 2021 | 7,672 | 10,169 (0%) | 0% | 440 | 3,375,680 | Common Stock |